Troyanovsky B, Levchenko T, Månsson G, Matvijenko O, Holmgren L. Angiomotin an angiostatin binding protein that regulates endothelial cell migration and tube formation. J Cell Biol. 2001;152:1247–54.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bratt A, Wilson WJ, Troyanovsky B, Aase K, Kessler R, Meir EGV, Holmgren L. Angiomotin belongs to a novel protein family with conserved coiled-coil and PDZ binding domains. Gene. 2002;298:69–77.
Article
CAS
PubMed
Google Scholar
Bratt A, Birot O, Sinha I, Veitonmäki N, Aase K, Ernkvist M, Holmgren L. Angiomotin regulates endothelial cell-cell junctions and cell motility. J Biol Chem. 2005;280:34859–69.
Article
CAS
PubMed
Google Scholar
Ernkvist M, Aase K, Ukomadu C, Wohlschlegel J, Blackman R, Veitonmäki N, Bratt A, Dutta A, Holmgren L. p130-Angiomotin associates to actin and controls endothelial cell shape. FEBS J. 2006;273:2000–11.
Article
CAS
PubMed
Google Scholar
Webb C, Upadhyay A, Giuntini F, Eggleston I, Furutani-Seiki M, Ishima R, Bagby S. Structural features and ligand binding properties of tandem WW domains from YAP and TAZ, nuclear effectors of the Hippo pathway. Biochemistry. 2011;50:3300–9.
Article
CAS
PubMed
Google Scholar
Zhao B, Li L, Lu Q, Wang LH, Liu C-Y, Lei Q, Guan K-L. Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein. Genes Dev. 2011;25:51–63.
Article
PubMed
PubMed Central
Google Scholar
Ren J, Wen L, Gao X, Jin C, Xue Y, Yao X. DOG 1.0: illustrator of protein domain structures. Cell Res. 2009;19:271–3.
Article
CAS
PubMed
Google Scholar
Wang C, An J, Zhang P, Xu C, Gao K, Wu D, Wang D, Yu H, Liu JO, Yu L. The Nedd4-like ubiquitin E3 ligases target Angiomotin/p130 to ubiquitin-dependent degradation. Biochem J. 2012;444:279–89.
Article
CAS
PubMed
Google Scholar
Liu W, Xie Y, Ma J, Luo X, Nie P, Zuo Z, Lahrmann U, Zhao Q, Zheng Y, Zhao Y. IBS: an illustrator for the presentation and visualization of biological sequences. Bioinformatics. 2015;31:3359–61.
Article
CAS
PubMed
PubMed Central
Google Scholar
Moreau J, Lord M, Boucher M, Belleau P, Fernandes MJG. Protein diversity is generated within the motin family of proteins by alternative pre-mRNA splicing. Gene. 2005;350:137–48.
Article
CAS
PubMed
Google Scholar
Moleirinho S, Guerrant W, Kissil JL. The Angiomotins–from discovery to function. FEBS Lett. 2014;588:2693–703.
Article
CAS
PubMed
PubMed Central
Google Scholar
Marikawa Y, Alarcón VB. Establishment of trophectoderm and inner cell mass lineages in the mouse embryo. Mol Reprod Dev. 2009;76:1019–32.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hirate Y, Sasaki H. The role of Angiomotin phosphorylation in the Hippo pathway during preimplantation mouse development. Tissue Barriers. 2014;2:1181–94.
Article
Google Scholar
Sasaki H. Position-and polarity-dependent Hippo signaling regulates cell fates in preimplantation mouse embryos. Amsterdam: Elsevier; 2015. p. 80–7.
Google Scholar
Nishioka N, Inoue K-I, Adachi K, Kiyonari H, Ota M, Ralston A, Yabuta N, Hirahara S, Stephenson RO, Ogonuki N. The Hippo signaling pathway components Lats and Yap pattern Tead4 activity to distinguish mouse trophectoderm from inner cell mass. Dev Cell. 2009;16:398–410.
Article
CAS
PubMed
Google Scholar
Dai X, She P, Chi F, Feng Y, Liu H, Jin D, Zhao Y, Guo X, Jiang D, Guan K-L. Phosphorylation of Angiomotin by Lats1/2 kinases inhibits F-actin binding, cell migration, and angiogenesis. J Biol Chem. 2013;288:34041–51.
Article
CAS
PubMed
PubMed Central
Google Scholar
Mihajlović AI, Bruce AW. Rho-associated protein kinase regulates subcellular localisation of Angiomotin and Hippo-signalling during preimplantation mouse embryo development. Reprod BioMed Online. 2016;33:381–90.
Article
PubMed
Google Scholar
Hirate Y, Hirahara S, Inoue K-I, Suzuki A, Alarcon VB, Akimoto K, Hirai T, Hara T, Adachi M, Chida K. Polarity-dependent distribution of angiomotin localizes Hippo signaling in preimplantation embryos. Curr Biol. 2013;23:1181–94.
Article
CAS
PubMed
PubMed Central
Google Scholar
Matsumoto H, Fukui E, Yoshizawa M, Sato E, Daikoku T. Differential expression of the motin family in the peri-implantation mouse uterus and their hormonal regulation. J Reprod Dev. 2012;58:649–53.
Article
CAS
PubMed
Google Scholar
Shimono A, Behringer RR. Angiomotin regulates visceral endoderm movements during mouse embryogenesis. Curr Biol. 2003;13:613–7.
Article
CAS
PubMed
Google Scholar
Huang H, Lu F-I, Jia S, Meng S, Cao Y, Wang Y, Ma W, Yin K, Wen Z, Peng J. Amotl2 is essential for cell movements in zebrafish embryo and regulates c-Src translocation. Development. 2007;134:979–88.
Article
CAS
PubMed
Google Scholar
Li Z, Wang Y, Zhang M, Xu P, Huang H, Wu D, Meng A. The Amotl2 gene inhibits Wnt/β-catenin signaling and regulates embryonic development in zebrafish. J Biol Chem. 2012;287:13005–15.
Article
CAS
PubMed
PubMed Central
Google Scholar
Aase K, Ernkvist M, Ebarasi L, Jakobsson L, Majumdar A, Yi C, Birot O, Ming Y, Kvanta A, Edholm D. Angiomotin regulates endothelial cell migration during embryonic angiogenesis. Genes Dev. 2007;21:2055–68.
Article
CAS
PubMed
PubMed Central
Google Scholar
Levchenko T, Aase K, Troyanovsky B, Bratt A, Holmgren L. Loss of responsiveness to chemotactic factors by deletion of the C-terminal protein interaction site of Angiomotin. J Cell Sci. 2003;116:3803–10.
Article
CAS
PubMed
Google Scholar
Xiao J, Jin K, Wang J, Ma J, Zhang J, Jiang N, Wang H, Luo X, Fei J, Wang Z. Conditional knockout of TFPI-1 in VSMCs of mice accelerates atherosclerosis by enhancing AMOT/YAP pathway. Int J Cardiol. 2017;228:605–14.
Article
PubMed
Google Scholar
Wells CD, Fawcett JP, Traweger A, Yamanaka Y, Goudreault M, Elder K, Kulkarni S, Gish G, Virag C, Lim C. A Rich1/Amot complex regulates the Cdc42 GTPase and apical-polarity proteins in epithelial cells. Cell. 2006;125:535–48.
Article
CAS
PubMed
Google Scholar
Sugihara-Mizuno Y, Adachi M, Kobayashi Y, Hamazaki Y, Nishimura M, Imai T, Furuse M, Tsukita S. Molecular characterization of Angiomotin/JEAP family proteins: interaction with MUPP1/Patj and their endogenous properties. Genes Cells. 2007;12:473–86.
Article
CAS
PubMed
Google Scholar
Sistani L, Dunér F, Udumala S, Hultenby K, Uhlen M, Betsholtz C, Tryggvason K, Wernerson A, Patrakka J. Pdlim2 is a novel actin-regulating protein of podocyte foot processes. Kidney Int. 2011;80:1045–54.
Article
CAS
PubMed
Google Scholar
Levchenko T, Veitonmäki N, Lundkvist A, Gerhardt H, Ming Y, Berggren K, Kvanta A, Carlsson R, Holmgren L. Therapeutic antibodies targeting Angiomotin inhibit angiogenesis in vivo. FASEB J. 2008;22:880–9.
Article
CAS
PubMed
Google Scholar
Wu C, Agrawal S, Vasanji A, Drazba J, Sarkaria S, Xie J, Welch CM, Liu M, Anand-Apte B, Horowitz A. Rab13-dependent trafficking of RhoA is required for directional migration and angiogenesis. J Biol Chem. 2011;286:23511–20.
Article
CAS
PubMed
PubMed Central
Google Scholar
Garnaas MK, Moodie KL, Liu ML, Samant GV, Li K, Marx R, Baraban JM, Horowitz A, Ramchandran R. Syx, a RhoA guanine exchange factor, is essential for angiogenesis in vivo. Circ Res. 2008;103:710–6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ernkvist M, Persson NL, Audebert S, Lecine P, Sinha I, Liu M, Schlueter M, Horowitz A, Aase K, Weide T. The Amot/Patj/Syx signaling complex spatially controls RhoA GTPase activity in migrating endothelial cells. Blood. 2009;113:244–53.
Article
CAS
PubMed
PubMed Central
Google Scholar
Niu X, Chang W, Liu R, Hou R, Li J, Wang C, Li X, Zhang K. mRNA and protein expression of theangiogenesis-related genes EDIL3, AMOT and ECM1 in mesenchymal stem cells in psoriatic dermis. ClinExp Dermatol. 2016;41:533–40.
CAS
Google Scholar
Ernkvist M, Birot O, Sinha I, Veitonmaki N, Nyström S, Aase K, Holmgren L. Differential roles of p80-and p130-Angiomotin in the switch between migration and stabilization of endothelial cells. Biochimica et Biophysica Acta (BBA)-Mol Cell Res. 2008;1783:429–37.
Article
CAS
Google Scholar
Roudier E, Chapados N, Decary S, Gineste C, Le Bel C, Lavoie JM, Bergeron R, Birot O. Angiomotin p80/p130 ratio: a new indicator of exercise-induced angiogenic activity in skeletal muscles from obese and non-obese rats? J Physiol. 2009;587:4105–19.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zheng Y, Vertuani S, Nyström S, Audebert S, Meijer I, Tegnebratt T, Borg J-P, Uhlén P, Majumdar A, Holmgren L. Angiomotin-like protein 1 controls endothelial polarity and junction stability during sprouting angiogenesis. Circ Res. 2009;105:260–70.
Article
CAS
PubMed
Google Scholar
Gagné V, Moreau J, Plourde M, Lapointe M, Lord M, Gagnon É, Fernandes MJG. Human Angiomotin-like 1 associates with an Angiomotin protein complex through its coiled-coil domain and induces the remodeling of the actin cytoskeleton. Cell Motil Cytoskelet. 2009;66:754–68.
Article
Google Scholar
Choi K-S, Choi H-J, Lee J-K, Im S, Zhang H, Jeong Y, Park JA, Lee I-K, Kim Y-M, Kwon Y-G. The endothelial E3 ligase HECW2 promotes endothelial cell junctions by increasing AMOTL1 protein stability via K63-linked ubiquitination. Cell Signal. 2016;28:1642–51.
Article
CAS
PubMed
Google Scholar
Zheng Y, Zhang Y, Barutello G, Chiu K, Arigoni M, Giampietro C, Cavallo F, Holmgren L. Angiomotin like-1 is a novel component of the N-cadherin complex affecting endothelial/pericyte interaction in normal and tumor angiogenesis. Sci Rep. 2016;6:30622.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wang Y, Li Z, Xu P, Huang L, Tong J, Huang H, Meng A. Angiomotin-like2 gene (amotl2) is required for migration and proliferation of endothelial cells during angiogenesis. J Biol Chem. 2011;286:41095–104.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hultin S, Zheng Y, Mojallal M, Vertuani S, Gentili C, Balland M, Milloud R, Belting H-G, Affolter M, Helker CSM. AmotL2 links VE-cadherin to contractile actin fibres necessary for aortic lumen expansion. Nat Commun. 2014;5:3743.
Article
CAS
PubMed
Google Scholar
Zhao B, Tumaneng K, Guan K-L. The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal. Nat Cell Biol. 2011;13:877–83.
Article
CAS
PubMed
PubMed Central
Google Scholar
Pan D. The hippo signaling pathway in development and cancer. Dev Cell. 2010;19:491–505.
Article
CAS
PubMed
PubMed Central
Google Scholar
Edgar BA. From cell structure to transcription: hippo forges a new path. Cell. 2006;124:267–73.
Article
CAS
PubMed
Google Scholar
Chen L, Loh PG, Song H. Structural and functional insights into the TEAD-YAP complex in the Hippo signaling pathway. Protein Cell. 2010;1:1073–83.
Article
CAS
PubMed
Google Scholar
Bossuyt W, Chen CL, Chen Q, Sudol M, McNeill H, Pan D, Kopp A, Halder G. An evolutionary shift in the regulation of the Hippo pathway between mice and flies. Oncogene. 2014;33:1218–28.
Article
CAS
PubMed
Google Scholar
Moleirinho S, Hoxha S, Mandati V, Curtale G, Troutman S, Ehmer U, Kissil JL. Regulation of localization and function of the transcriptional co-activator YAP by Angiomotin. Elife. 2017;6:1–23.
Article
Google Scholar
Yi C, Troutman S, Fera D, Stemmer-Rachamimov A, Avila JL, Christian N, Persson NL, Shimono A, Speicher DW, Marmorstein R. A tight junction-associated Merlin-Angiomotin complex mediates Merlin’s regulation of mitogenic signaling and tumor suppressive functions. Cancer Cell. 2011;19:527–40.
Article
CAS
PubMed
PubMed Central
Google Scholar
Li Y, Zhou H, Li F, Chan SW, Lin Z, Wei Z, Yang Z, Guo F, Lim CJ, Xing W. Angiomotin binding-induced activation of Merlin/NF2 in the Hippo pathway. Cell Res. 2015;25:801–17.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sowa ME, Bennett EJ, Gygi SP, Harper JW. Defining the human deubiquitinating enzyme interaction landscape. Cell. 2009;138:389–403.
Article
CAS
PubMed
PubMed Central
Google Scholar
Oka T, Schmitt AP, Sudol M. Opposing roles of Angiomotin-like-1 and zona occludens-2 on pro-apoptotic function of YAP. Oncogene. 2012;31:128–34.
Article
CAS
PubMed
Google Scholar
DeRan M, Yang J, Shen C-H, Peters EC, Fitamant J, Chan P, Hsieh M, Zhu S, Asara JM, Zheng B. Energy stress regulates hippo-YAP signaling involving AMPK-mediated regulation of Angiomotin-like 1 protein. Cell Rep. 2014;9:495–503.
Article
CAS
PubMed
PubMed Central
Google Scholar
Agarwala S, Duquesne S, Liu K, Boehm A, Grimm L, Link S, König S, Eimer S, Ronneberger O, Lecaudey V. Amotl2a interacts with the Hippo effector Yap1 and the Wnt/β-catenin effector Lef1 to control tissue size in zebrafish. Elife. 2015;4:e08201.
Article
PubMed
PubMed Central
Google Scholar
Kim M, Kim M, Park SJ, Lee C, Lim DS. Role of Angiomotin-like 2 mono-ubiquitination on YAP inhibition. EMBO Rep. 2016;17:64–78.
Article
CAS
PubMed
Google Scholar
Chan SW, Lim CJ, Chong YF, Pobbati AV, Huang C, Hong W. Hippo pathway-independent restriction of TAZ and YAP by Angiomotin. J Biol Chem. 2011;286:7018–26.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cox CM, Mandell EK, Stewart L, Lu R, Johnson DL, McCarter SD, Tavares A, Runyan R, Ghosh S, Wilson JM. Endosomal regulation of contact inhibition through the AMOT: YAP pathway. Mol Biol Cell. 2015;26:2673–84.
Article
CAS
PubMed
PubMed Central
Google Scholar
Skouloudaki K, Walz G. YAP1 recruits c-Abl to protect Angiomotin-like 1 from Nedd4-mediated degradation. PLoS ONE. 2012;7:e35735.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wang J, Wang H, Zhang Y, Zhen N, Zhang L, Qiao Y, Weng W, Liu X, Ma L, Xiao W. Mutual inhibition between YAP and SRSF1 maintains long non-coding RNA, Malat1-induced tumourigenesis in liver cancer. Cell Signal. 2014;26:1048–59.
Article
CAS
PubMed
Google Scholar
Hsu YL, Hung JY, Chou SH, Huang MS, Tsai MJ, Lin YS, Chiang SY, Ho YW, Wu CY, Kuo PL. Angiomotin decreases lung cancer progression by sequestering oncogenic YAP/TAZ and decreasing Cyr61 expression. Oncogene. 2015;34:4056–68.
Article
CAS
PubMed
Google Scholar
Wang H, Lu B, Castillo J, Zhang Y, Yang Z, McAllister G, Lindeman A, Reece-Hoyes J, Tallarico J, Russ C. Tankyrase inhibitor sensitizes lung cancer cells to endothelial growth factor receptor (EGFR) inhibition via stabilizing Angiomotins and inhibiting YAP signaling. J Biol Chem. 2016;291:15256–66.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wang W, Li N, Li X, Tran MK, Han X, Chen J. Tankyrase inhibitors target YAP by stabilizing Angiomotin family proteins. Cell Rep. 2015;13:524–32.
Article
PubMed
PubMed Central
Google Scholar
Troilo A, Benson EK, Esposito D, Garibsingh RA, Reddy EP, Mungamuri SK, Aaronson SA. Angiomotin stabilization by tankyrase inhibitors antagonizes constitutive TEAD-dependent transcription and proliferation of human tumor cells with Hippo pathway core component mutations. Oncotarget. 2016;7:28765–82.
Article
PubMed
PubMed Central
Google Scholar
Nguyen HT, Kugler J-M, Cohen SM. DUB3 deubiquitylating enzymes regulate Hippo pathway activity by regulating the stability of ITCH, LATS and AMOT proteins. PloS ONE. 2017;12:e0169587.
Article
PubMed
PubMed Central
Google Scholar
Adler JJ, Heller BL, Bringman LR, Ranahan WP, Cocklin RR, Goebl MG, Oh M, Lim H-S, Ingham RJ, Wells CD. Amot130 adapts atrophin-1 interacting protein 4 to inhibit yes-associated protein signaling and cell growth. J Biol Chem. 2013;288:15181–93.
Article
CAS
PubMed
PubMed Central
Google Scholar
Paramasivam M, Sarkeshik A, Yates JR, Fernandes MJG, McCollum D. Angiomotin family proteins are novel activators of the LATS2 kinase tumor suppressor. Mol Biol Cell. 2011;22:3725–33.
Article
CAS
PubMed
PubMed Central
Google Scholar
Adler JJ, Johnson DE, Heller BL, Bringman LR, Ranahan WP, Conwell MD, Sun Y, Hudmon A, Wells CD. Serum deprivation inhibits the transcriptional co-activator YAP and cell growth via phosphorylation of the 130-kDa isoform of Angiomotin by the LATS1/2 protein kinases. Proc Natl Acad Sci. 2013;110:17368–73.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chan SW, Lim CJ, Guo F, Tan I, Leung T, Hong W. Actin-binding and cell proliferation activities of Angiomotin family members are regulated by Hippo pathway-mediated phosphorylation. J Biol Chem. 2013;288:37296–307.
Article
CAS
PubMed
PubMed Central
Google Scholar
Mana-Capelli S, Paramasivam M, Dutta S, McCollum D. Angiomotins link F-actin architecture to Hippo pathway signaling. Mol Biol Cell. 2014;25:1676–85.
Article
PubMed
PubMed Central
Google Scholar
Wang W, Huang J, Chen J. Angiomotin-like proteins associate with and negatively regulate YAP1. J Biol Chem. 2011;286:4364–70.
Article
CAS
PubMed
Google Scholar
Campbell CI, Samavarchi-Tehrani P, Barrios-Rodiles M, Datti A, Gingras A-C, Wrana JL. The RNF146 and tankyrase pathway maintains the junctional Crumbs complex through regulation of Angiomotin. J Cell Sci. 2016;129:3396–411.
Article
CAS
PubMed
Google Scholar
Lv M, Lv M, Chen L, Qin T, Zhang X, Liu P, Yang J. Angiomotin promotes breast cancer cell proliferation and invasion. Oncol Rep. 2015;33:1938–46.
Article
CAS
PubMed
Google Scholar
Lv M, Li S, Luo C, Zhang X, Shen Y, Sui Y, Wang F, Wang X, Yang J, Liu P. Angiomotin promotes renal epithelial and carcinoma cell proliferation by retaining the nuclear YAP. Oncotarget. 2016;7:12393–403.
PubMed
PubMed Central
Google Scholar
Wang Y, Justilien V, Brennan KI, Jamieson L, Murray NR, Fields AP. PKCι regulates nuclear YAP1 localization and ovarian cancer tumorigenesis. Oncogene. 2017;36:534–45.
Article
CAS
PubMed
Google Scholar
Zeng H, Ortiz A, Shen P-F, Cheng C-J, Lee Y-C, Yu G, Lin S-C, Creighton CJ, Yu-Lee L-Y, Lin S-H. Angiomotin regulates prostate cancer cell proliferation by signaling through the Hippo-YAP pathway. Oncotarget. 2017;8:10145.
PubMed
Google Scholar
Yi C, Shen Z, Stemmer-Rachamimov A, Dawany N, Troutman S, Showe LC, Liu Q, Shimono A, Sudol M, Holmgren L. The p130 isoform of Angiomotin is required for Yap-mediated hepatic epithelial cell proliferation and tumorigenesis. Sci Signal. 2013;6:ra77.
Article
PubMed
PubMed Central
Google Scholar
Artinian N, Cloninger C, Holmes B, Benavides-Serrato A, Bashir T, Gera J. Phosphorylation of the Hippo pathway component AMOTL2 by the mTORC2 kinase promotes YAP signaling, resulting in enhanced glioblastoma growth and invasiveness. J Biol Chem. 2015;290:19387–401.
Article
CAS
PubMed
PubMed Central
Google Scholar
Levchenko T, Bratt A, Arbiser JL, Holmgren L. Angiomotin expression promotes hemangioendothelioma invasion. Oncogene. 2004;23:1469–73.
Article
CAS
PubMed
Google Scholar
Jiang WG, Watkins G, Douglas-Jones A, Holmgren L, Mansel RE. Angiomotin and Angiomotin like proteins, their expression and correlation with angiogenesis and clinical outcome in human breast cancer. BMC Cancer. 2006;6:1.
Article
Google Scholar
Arigoni M, Barutello G, Lanzardo S, Longo D, Aime S, Curcio C, Iezzi M, Zheng Y, Barkefors I, Holmgren L. A vaccine targeting Angiomotin induces an antibody response which alters tumor vessel permeability and hampers the growth of established tumors. Angiogenesis. 2012;15:305–16.
Article
CAS
PubMed
PubMed Central
Google Scholar
Holmgren L, Ambrosino E, Birot O, Tullus C, Veitonmäki N, Levchenko T, Carlson L-M, Musiani P, Iezzi M, Curcio C. A DNA vaccine targeting Angiomotin inhibits angiogenesis and suppresses tumor growth. Proc Natl Acad Sci. 2006;103:9208–13.
Article
CAS
PubMed
PubMed Central
Google Scholar
Stalin J, Harhouri K, Hubert L, Subrini C, Lafitte D, Lissitzky J-C, Elganfoud N, Robert S, Foucault-Bertaud A, Kaspi E. Soluble melanoma cell adhesion molecule (sMCAM/sCD146) promotes angiogenic effects on endothelial progenitor cells through Angiomotin. J Biol Chem. 2013;288:8991–9000.
Article
CAS
PubMed
PubMed Central
Google Scholar
Yang J, Liu P, Tian M, Li Y, Chen W, Li X. Proteomic identification of Angiomotin by ProteomeLab PF-2D and correlation with clinical outcome in human clear cell renal cell carcinoma. Int J Oncol. 2013;42:2078–86.
Article
CAS
PubMed
Google Scholar
Byun JY, Lee SH, Shin JM, Baek BJ, Lee JY. Overexpression of Angiomotin in sinonasal inverted papilloma. Int Forum Allergy Rhinol. 2014;4(6):512–6.
Article
PubMed
Google Scholar
Hakami F, Darda L, Stafford P, Woll P, Lambert DW, Hunter KD. The roles of HOXD10 in the development and progression of head and neck squamous cell carcinoma (HNSCC). Br J Cancer. 2014;111:807–16.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ortiz A, Lee Y-C, Yu G, Liu H-C, Lin S-C, Bilen MA, Cho H, Yu-Lee L-Y, Lin S-H. Angiomotin is a novel component of cadherin-11/β-catenin/p120 complex and is critical for cadherin-11-mediated cell migration. FASEB J. 2015;29:1080–91.
Article
CAS
PubMed
Google Scholar
Zhang Y, Yuan J, Zhang X, Yan F, Huang M, Wang T, Zheng X, Zhang M. Angiomotin promotes the malignant potential of colon cancer cells by activating the YAP-ERK/PI3K-AKT signaling pathway. Oncol Rep. 2016;36:3619–26.
Article
CAS
PubMed
Google Scholar
Ruan W, Wang P, Feng S, Xue Y, Li Y. Long non-coding RNA small nucleolar RNA host gene 12 (SNHG12) promotes cell proliferation and migration by upregulating Angiomotin gene expression in human osteosarcoma cells. Tumor Biol. 2016;37:4065–73.
Article
CAS
Google Scholar
Ruan W-D, Wang P, Feng S, Xue Y, Zhang B. MicroRNA-497 inhibits cell proliferation, migration, and invasion by targeting AMOT in human osteosarcoma cells. OncoTargets Ther. 2016;9:303.
Article
CAS
Google Scholar
Zhang H, Fan Q. MicroRNA-205 inhibits the proliferation and invasion of breast cancer by regulating AMOT expression. Oncol Rep. 2015;34:2163–70.
Article
CAS
PubMed
Google Scholar
Mojallal M, Zheng Y, Hultin S, Audebert S, van Harn T, Johnsson P, Lenander C, Fritz N, Mieth C, Corcoran M. AmotL2 disrupts apical–basal cell polarity and promotes tumour invasion. Nat Commun. 2014;5:4557.
Article
CAS
PubMed
Google Scholar
Han H, Yang B, Wang W. Angiomotin-like 2 interacts with and negatively regulates AKT. Oncogene. 2017;36(32):4662.
Article
CAS
PubMed
Google Scholar
Mercenne G, Alam SL, Arii J, Lalonde MS, Sundquist WI. Angiomotin functions in HIV-1 assembly and budding. Elife. 2015;4:e03778.
Article
PubMed Central
Google Scholar
Pei Z, Bai Y, Schmitt AP. PIV5 M protein interaction with host protein Angiomotin-like 1. Virology. 2010;397:155–66.
Article
CAS
PubMed
Google Scholar
Park MC, Chung SJ, Park YB, Lee SK. Relationship of angiogenic factors to disease activity and radiographic damage in rheumatoid arthritis. Clin Exp Rheumatol. 2008;26:881.
PubMed
Google Scholar
Celec P, Hodosy J, Gardlík R, Behuliak M, Pálffy R, Pribula M, Jáni P, Turňa J, Šebeková K. The effects of anti-inflammatory and anti-angiogenic DNA vaccination on diabetic nephropathy in rats. Hum Gene Ther. 2011;23:158–66.
Article
PubMed Central
Google Scholar
Lucci V, Di Palma T, D’Ambrosio C, Scaloni A, Zannini M. AMOTL2 interaction with TAZ causes the inhibition of surfactant proteins expression in lung cells. Gene. 2013;529:300–6.
Article
CAS
PubMed
Google Scholar
Proszynski TJ, Sanes JR. Amotl2 interacts with LL5β, localizes to podosomes and regulates postsynaptic differentiation in muscle. J Cell Sci. 2013;126:2225–35.
Article
CAS
PubMed
PubMed Central
Google Scholar
Nguyen HT, Andrejeva D, Gupta R, Choudhary C, Hong X, Eichhorn PJA, Loya AC, Cohen SM. Deubiquitylating enzyme USP9x regulates Hippo pathway activity by controlling Angiomotin protein turnover. Cell Discov. 2016;2:16001.
Article
Google Scholar
Couderc C, Boin A, Fuhrmann L, Vincent-Salomon A, Mandati V, Kieffer Y, Mechta-Grigoriou F, Del Maestro L, Chavrier P, Vallerand D. AMOTL1 promotes breast cancer progression and is antagonized by merlin. Neoplasia. 2016;18:10–24.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wan H-Y, Li Q-Q, Zhang Y, Tian W, Li Y-N, Liu M, Li X, Tang H. MiR-124 represses vasculogenic mimicry and cell motility by targeting amotL1 in cervical cancer cells. Cancer Lett. 2014;355:148–58.
Article
CAS
PubMed
Google Scholar